Fiera Capital Corp Bei Gene, Ltd. Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

A detailed history of Fiera Capital Corp transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Fiera Capital Corp holds 6,011 shares of BGNE stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,011

Previous 3,736 60.89%

Holding current value

$1.15 Million

Previous $533,000 153.1%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$143.93 - $224.51 $327,440 - $510,760	2,275 Added 60.89%	6,011 $1.35 Million
Q2 2024 Aug 01, 2024	BUY	$129.52 - $174.32 $152,315 - $205,000	1,176 Added 45.94%	3,736 $533,000
Q1 2024 Aug 22, 2024	SELL	$141.8 - $181.47 $166,756 - $213,408	-1,176 Reduced 31.48%	2,560 $400,000
Q1 2024 May 01, 2024	SELL	$141.8 - $181.47 $825,276 - $1.06 Million	-5,820 Reduced 69.45%	2,560 $400,000
Q4 2023 Aug 22, 2024	SELL	$158.67 - $201.58 $31,733 - $40,316	-200 Reduced 2.33%	8,380 $1.51 Million
Q4 2023 Feb 08, 2024	SELL	$158.67 - $201.58 $31,733 - $40,316	-200 Reduced 2.33%	8,380 $1.51 Million
Q3 2023 Aug 22, 2024	BUY	$179.87 - $225.13 $871,290 - $1.09 Million	4,844 Added 129.66%	8,580 $1.54 Million
Q3 2023 Nov 09, 2023	BUY	$179.87 - $225.13 $41,549 - $52,005	231 Added 2.77%	8,580 $1.54 Million
Q2 2023 Aug 09, 2023	SELL	$178.3 - $266.78 $33,520 - $50,154	-188 Reduced 2.2%	8,349 $1.49 Million
Q1 2023 Apr 26, 2023	BUY	$215.53 - $274.5 $57,330 - $73,017	266 Added 3.22%	8,537 $1.84 Million
Q4 2022 Feb 08, 2023	BUY	$125.51 - $229.3 $50,580 - $92,407	403 Added 5.12%	8,271 $1.82 Million
Q1 2022 May 09, 2022	SELL	$146.52 - $269.56 $19.4 Million - $35.7 Million	-132,515 Reduced 94.4%	7,868 $1.48 Million
Q4 2021 Feb 08, 2022	SELL	$248.56 - $389.34 $1.21 Million - $1.89 Million	-4,856 Reduced 3.34%	140,383 $38 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $638,726 - $1.03 Million	-2,559 Reduced 1.73%	145,239 $52.7 Million
Q2 2021 Aug 11, 2021	SELL	$292.75 - $367.01 $1.03 Million - $1.29 Million	-3,503 Reduced 2.32%	147,798 $27.8 Million
Q1 2021 May 11, 2021	SELL	$260.64 - $382.12 $1.05 Million - $1.53 Million	-4,014 Reduced 2.58%	151,301 $52.7 Million
Q4 2020 Feb 09, 2021	BUY	$221.31 - $316.61 $133,007 - $190,282	601 Added 0.39%	155,315 $40.1 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $862,282 - $1.31 Million	-4,558 Reduced 2.86%	154,714 $44.3 Million
Q2 2020 Aug 07, 2020	SELL	$123.9 - $195.41 $655,431 - $1.03 Million	-5,290 Reduced 3.21%	159,272 $30 Million
Q1 2020 May 08, 2020	SELL	$121.84 - $173.19 $1.27 Million - $1.8 Million	-10,396 Reduced 5.94%	164,562 $20.3 Million
Q4 2019 Feb 06, 2020	SELL	$115.78 - $208.34 $1.97 Million - $3.54 Million	-16,992 Reduced 8.85%	174,958 $29 Million
Q3 2019 Nov 12, 2019	SELL	$120.61 - $148.29 $127,605 - $156,890	-1,058 Reduced 0.55%	191,950 $23.5 Million
Q2 2019 Aug 12, 2019	SELL	$113.99 - $146.86 $1.5 Million - $1.93 Million	-13,154 Reduced 6.38%	193,008 $23.9 Million
Q1 2019 May 10, 2019	SELL	$122.82 - $151.83 $1.14 Million - $1.41 Million	-9,302 Reduced 4.32%	206,162 $27.2 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $22.4 Million - $36.7 Million	209,568 Added 3554.41%	215,464 $30.2 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $899,847 - $1.12 Million	5,896 New	5,896 $1.02 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Bei Gene, Ltd. Transaction History